Treating Kaposi's lesions in the HIV-infected patient.

Abstract

Kaposi's sarcoma is the most frequent malignant neoplasm in AIDS, occurring in about 10 percent of all risk groups. This study evaluates the effect of intralesional vinblastine on intraoral Kaposi's sarcoma in 24 HIV-positive, homosexual males with 82 lesions. Complete resolution occurred in nearly 70 percent of the cases.

• Authors: C M Nichols, C M Flaitz, M J Hicks
• Journal: Journal of the American Dental Association (1939) (J Am Dent Assoc) Vol. 124 Issue 11 Pg. 78-84 (Nov 1993) ISSN: 0002-8177 [Print] England
• PMID: 8227776 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Vinblastine

Topics

• Adult
• Follow-Up Studies
• HIV Infections (complications)
• Homosexuality
• Humans
• Male
• Middle Aged
• Mouth Neoplasms (drug therapy, etiology)
• Neoplasm Recurrence, Local
• Sarcoma, Kaposi (drug therapy, etiology)
• Vinblastine (administration & dosage)